Abstract
Hypogylcaemia
is the presence of abnormally low blood
sugar and can have multiple causes including
iatrogenic side effects of diabetic medications.
Hypoglycaemia increases morbidity and
mortality in diabetic patients. It can
also adversely affect the productivity
and quality of life of patients.
We document the
several consequences of hypo-glycaemia
including increased susceptibility to
cardiac and neurological events.
We recommend tailored
and structured patient education to ensure
adequate knowledge about the causes and
management of hypoglycaemia.
We envisage that
over time increasing use of continuous
glucose monitoring and automatic hypoglycaemic
alerts will reduce the morbidity and mortality
burden of hypoglycaemia.
Key words:
hypoglycaemia, iatrogenic side effects,
diabetes
Terms:
DM: Diabetes Mellitus,
DCCT: (Diabetes Control and Complications
Trial),
IQ:
Intelligence Quotient,
HbA1c: Hemoglobin A1c,
MRI: Magnetic Resonance Imaging,
GLP 1: Glucagon- like peptide 1
receptor agonist,
SGLT-2: Sodium glucose co transporter
-2,
DPP-4 Dipeptidyl peptidase 4,
CGM: continuous glucose monitoring.
|